Seen in the press: Nemera’s article featured in April ‘Pulmonary and Nasal Delivery’


‘Pulmonary and Nasal Delivery’ magazine features Nemera’s article about RetroNose Concept.

The recently published ‘Pulmonary and Nasal delivery’ magazine includes an article from Nemera:  “Deposition in three nasal cast models using RetroNose Concept”.

In this article, Laurent Vecellio, PhD, Research Engineer, CEPR, INSERM U1100, University of Tours, and Scientific Director, Nemera; Déborah Le Pennec, Research Technician, CEPR, INSERM U1100, University of Tours; Guillaume Grevin, Senior Design Engineer, Nemera; and Alain Regard, Technology Product Manager, Nemera; discuss a study conducted to test particle deposition characteristics of the RetroNose device prototype for nasal drug delivery.

The RetroNose concept was born after a high variability in deposition was observed for the nasal spray compared with the RetroNose prototype device for the different regions of nasal cavities, except for in the middle part. The prototype uses a pMDI to administer the drug through the buccal cavity during the nasal expiratory phase.

The RetroNose is an alternate nasal delivery device concept to achieve better drug deposition in the different regions of the nose.


For more information, you can visit us at the Respiratory Drug Delivery Conference in Lisbon on from May 7 to May 9.

The full article:

The full issue of the magazine:

About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.

Nemera’s services and products cover several key delivery routes: Ophthalmic, Nasal, Buccal, Auricular, Inhalation, Dermal/Transdermal and Parenteral.

Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer IP manufacturing.